These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7418964)

  • 1. Hyperglucagonaemia in cirrhosis. Relationship to hepatocellular damage.
    Smith-Laing G; Orskov H; Gore MB; Sherlock S
    Diabetologia; 1980 Aug; 19(2):103-8. PubMed ID: 7418964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery.
    Alford FP; Dudley FJ; Chisholm DJ; Findlay DM
    Clin Endocrinol (Oxf); 1979 Oct; 11(4):413-24. PubMed ID: 519879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spontaneous portal-systemic shunting on insulin metabolism.
    Smith-Laing G; Sherlock S; Faber OK
    Gastroenterology; 1979 Apr; 76(4):685-90. PubMed ID: 421995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
    Gerö L; Korányi L; Szalay F; Büki B; Tamás G
    Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglucagonaemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic values.
    Lin HC; Yang MC; Hou MC; Lee FY; Huang YT; Lin LF; Li SM; Hwang SJ; Wang SS; Tsai YT; Lee SD
    J Gastroenterol Hepatol; 1996 May; 11(5):422-8. PubMed ID: 8743913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal and metabolic changes in hepatic cirrhosis.
    Johnston DG; Alberti KG; Binder C; Faber OK; Wright R; Orskov H
    Horm Metab Res; 1982 Jan; 14(1):34-9. PubMed ID: 7037586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
    Dudley FJ; Alford FP; Chisholm DJ; Findlay DM
    Gut; 1979 Oct; 20(10):817-24. PubMed ID: 533693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distal splenorenal shunt and insulin secretion, plasma glucagon, and glucose homeostasis in cirrhosis.
    Trevisani F; Bernardi M; Giancane S; Arienti V; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Nutrition; 1993; 9(2):133-9. PubMed ID: 8485325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating somatostatin concentrations in healthy and cirrhotic subjects.
    Verrillo A; de Teresa A; Martino C; Pinto M; Golia R
    Metabolism; 1986 Feb; 35(2):130-5. PubMed ID: 2868381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
    Kabadi UM; Eisenstein AB; Konda J
    Gastroenterology; 1985 Mar; 88(3):750-6. PubMed ID: 3881308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of the carbohydrate intolerance of cirrhosis.
    Proietto J; Alford FP; Dudley FJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1030-6. PubMed ID: 6999005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on glucose, amino acid and protein metabolism in patients with liver cirrhosis in relation to plasma levels of human growth hormone (author's transl)].
    Ogura C
    Hokkaido Igaku Zasshi; 1975 Sep; 50(5):489-506. PubMed ID: 815150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.